ReviewCurrent clinical microbiology reports2020
Reactive Arthritis: Update.
Review in Current clinical microbiology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 78 citations in OpenAlex.
- Article
- Article
- Reactive arthritis: a comprehensive journey through diagnostic findings.Skeletal radiology · 2025Review
- Article
- Extraintestinal Manifestations ofAntibiotics (Basel, Switzerland) · 2025Review
- Prevalence and Pathogenetic Mechanisms of Chronic Kidney Disease in Autoimmune-Mediated Systemic Diseases.Journal of clinical medicine research · 2025Review
- Diagnosis of rheumatic and autoimmune diseases dataset.Data in brief · 2025Article
- Article
- Fuzzy evaluation and explainable machine learning for diagnosis of rheumatic and autoimmune diseases.PeerJ. Computer science · 2025Article
- Native Joint Septic Arthritis.Antibiotics (Basel, Switzerland) · 2024Review
- Enteric Infection-Associated Reactive Arthritis: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- [Clinical relationship between reactive arthritis and SARS-CoV-2 infection: A scoping review].Revista colombiana de reumatologia · 2023Review
- Acute arthritis following SARS-CoV-2 infection: About two cases.Clinical case reports · 2023Article
- Development of Spondyloarthritis After COVID-19 in HLA-B27-Positive Monozygotic Twins: Case Reports With Single Cell Transcriptome Profiling.Journal of rheumatic diseases · 2023Article
- Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis.Clinical, cosmetic and investigational dermatology · 2022Article
- Article
- A Case Report and Review of the Literature: Reactive Arthritis Caused byFrontiers in microbiology · 2022Article
- Juvenile Reactive Arthritis and other Spondyloarthritides of Childhood: A 28-year Experience from India.Mediterranean journal of rheumatology · 2021Article
- Reactive arthritis after COVID-19: a case-based review.Rheumatology international · 2021Review
- A case report of monoarthritis in a COVID-19 patient and literature review: Simple actions for complex times.Medicine · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose of Review: The aim of this paper is to provide an overview about reactive arthritis, with an update regarding pathophysiology and therapeutic approach of the disease, outlining the clinical features and diagnostic approach, based on recent literature review. Recent Findings: Reactive arthritis is considered to be part of the spectrum of the spondyloarthritis. Its epidemiology is changing worldwide due to several reasons, among them are as follows: different diagnosis approach and clinical presentations, different grades of infection, microbiome changes, etc. The understanding of pathophysiological models is challenging, but recent studies contribute to elucidate the major factors involved in the development of the disease. The management of ReA depends on the triggering agent and the phase of disease, whether it is acute or chronic. Summary: The association between the microbiome changes and spondyloarthropathies (ReA) is becoming increasingly evident. The results regarding the biologic treatment on refectory ReA are promising.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.